Structural biology is a branch of molecular biology, biochemistry, and biophysics concerned with the molecular structure of biological macromolecules whereas Molecular Biology deals with the structure and function of the macromolecules which are essential to life. The major application of Structural Biology is Drug development and drug Discovery. Hence, it has significant potential due to the rising prevalence of chronic diseases and other diseases. The structural biology and molecular modelling field is concerned with how various molecules in biological compounds are arranged and how the peculiarity of the arrangement affects the nature of the compound.
The methods that structural biologists use to determine their structures generally involve measurements on vast numbers of identical molecules at the same time. These methods include:
Meet leading Structural and Molecular Biologists, Biochemistry researchers, Molecular diagnosticians, Pharmaceutical leaders, Scientists, Clinicians, Physicians, Doctors, Health care Professionals, researchers, Executives/Managers and Business Delegates, Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research & Diagnostic Laboratories, Clinical Fellows, Students, Biomedical and Biotechnology Research organizations, Structural Biology societies and associations, Molecular Biology societies and associations.
Rome is the most popular tourist attraction in Italy and serves as the 3rd most visited place in the European Union. The city is situated in the central-western portion of the Italian Peninsula, within Lazio (Latium), along the shores of the Tiber. It is the center of the Metropolitan City of Rome, which has 4.3 million residents. It is considered that Rome is home to world renowned universities, archaeological research, museums, entertainment venues and is major world centre of the Renaissance. Some of the tourist attract places in Rome may include Colosseum, Pantheon, Vatican Museums , St. Peter's Basilica, Squares and Fountains, Villa Borghese, Castel St. Angelo, Baths of Caracalla, Campidoglio and many more.
Structural Biology 2018 is a Rendezvous of Scientists, Researchers, Academic lecturers and Medical practitioners who are working towards more integrated approaches and effective responses to address the new advancement in structural and molecular biology field. This is your best opportunity to reach the largest assemblage of participants around the world in your field. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments and receive name recognition at this 3 day event. World renowned speakers, the most recent techniques, developments and the newest updates in structural biology and molecular biology are hallmarks of this conference.
The global Structural Biology and Molecular Modeling techniques market accounted for USD 2.52 billion in 2015 and is expected to grow at a CAGR of 18.2% over the coming years. The structural biology & molecular modeling techniques market is expected to reach USD 13.1 billion by 2025, according to a new study by Grand View Research, Inc whereas the global Molecular Biology Enzymes And Kits & Reagents market size was valued at USD 5.77 billion in 2016 and is expected to witness a CAGR of 19.0% during the forecast period. The market is predominantly driven by rise in the prevalence of chronic diseases with acquired drug resistance that exemplifies the need for new and advanced therapeutics. Moreover, increasing drug resistance coupled with the high drug attrition rate is engendering the requirement for extensive R&D activities, which is presumed to boost the adoption of structural biology & molecular modeling techniques in the drug discovery and development process. This is expected to serve as an efficient approach in fast tracking the development of drugs with high potency.
The demand of molecular modelling techniques is increasing as significant cost reduction enabled, due to the fact that prediction software identifies possible adverse reactions and determines drug efficacy and toxicity in the pre-clinical stages, thereby reducing the probability of drug failure at the later stages.
The Regional Scope for Structural and Molecular Biology is as North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Key companies profiled by the report that are actively underpinning growth of the market of Molecular Biology include Jena Bioscience GmbH, Takara Bio Inc., Roche Holdings, Inc., Illumina, Inc., Thermo Fisher Scientific Inc., Promega Corporation, KRISHGEN BioSystems, Agilent Technologies, Inc., Qiagen N.V., and Merck & Co Company.
NIH allots nearly $65 million annually for the determination of protein structure. National Institute on Drug Abuse (NIDA), Prevention Research, has funded $358.1 million in 2015. Annually, the California state invests $10-12 million in cancer research, while The National Cancer Institute (NCI) in United States spends $4.8 to $5.2 billion in cancer research. With the recent request for applications, the NIGMS expects to support three to six large research centers at a level of up to $3 million per centre.